China Biomarkers Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Biomarkers Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Biomarkers Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Biomarkers Overall Market Size
2.1 China Biomarkers Market Size: 2021 VS 2027
2.2 China Biomarkers Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Biomarkers Players in China Market
3.2 Top China Biomarkers Companies Ranked by Revenue
3.3 China Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Biomarkers Companies in China Market, by Revenue in 2020
3.5 Companies Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biomarkers Players in China Market
3.6.1 List of Tier 1 Biomarkers Companies in China
3.6.2 List of Tier 2 and Tier 3 Biomarkers Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Sepsis Biomarkers
4.1.3 Antibiotic Resistance Biomarkers
4.1.4 Traumatic Brain Injury (TBI) Testing Biomarkers
4.1.5 Stroke Testing Biomarkers
4.1.6 Antibiotic Stewardship Biomarkers
4.1.7 Other
4.2 By Type - China Biomarkers Revenue & Forecasts
4.2.1 By Type - China Biomarkers Revenue, 2016-2021
4.2.2 By Type - China Biomarkers Revenue, 2022-2027
4.2.3 By Type - China Biomarkers Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Biomarkers Market Size, 2021 & 2027
5.1.2 Diagnostics
5.1.3 Drug Discovery
5.1.4 Personalized Medicine
5.1.5 Other
5.2 By Application - China Biomarkers Revenue & Forecasts
5.2.1 By Application - China Biomarkers Revenue, 2016-2021
5.2.2 By Application - China Biomarkers Revenue, 2022-2027
5.2.3 By Application - China Biomarkers Revenue Market Share, 2016-2027

6 Biomarkers Companies Profiles
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Details
6.1.2 Thermo Fisher Scientific Business Overview
6.1.3 Thermo Fisher Scientific Biomarkers Introduction
6.1.4 Thermo Fisher Scientific Biomarkers Revenue in China Market (2016-2021)
6.1.5 Thermo Fisher Scientific Recent Developments
6.2 Merck
6.2.1 Merck Company Details
6.2.2 Merck Business Overview
6.2.3 Merck Biomarkers Introduction
6.2.4 Merck Biomarkers Revenue in China Market (2016-2021)
6.2.5 Merck Recent Developments
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Company Details
6.3.2 Bio-Rad Laboratories Business Overview
6.3.3 Bio-Rad Laboratories Biomarkers Introduction
6.3.4 Bio-Rad Laboratories Biomarkers Revenue in China Market (2016-2021)
6.3.5 Bio-Rad Laboratories Recent Developments
6.4 QIAGEN
6.4.1 QIAGEN Company Details
6.4.2 QIAGEN Business Overview
6.4.3 QIAGEN Biomarkers Introduction
6.4.4 QIAGEN Biomarkers Revenue in China Market (2016-2021)
6.4.5 QIAGEN Recent Developments
6.5 Roche
6.5.1 Roche Company Details
6.5.2 Roche Business Overview
6.5.3 Roche Biomarkers Introduction
6.5.4 Roche Biomarkers Revenue in China Market (2016-2021)
6.5.5 Roche Recent Developments
6.6 Danaher Corporation
6.6.1 Danaher Corporation Company Details
6.6.2 Danaher Corporation Business Overview
6.6.3 Danaher Corporation Biomarkers Introduction
6.6.4 Danaher Corporation Biomarkers Revenue in China Market (2016-2021)
6.6.5 Danaher Corporation Recent Developments
6.7 Siemens Healthcare
6.7.1 Siemens Healthcare Company Details
6.7.2 Siemens Healthcare Business Overview
6.7.3 Siemens Healthcare Biomarkers Introduction
6.7.4 Siemens Healthcare Biomarkers Revenue in China Market (2016-2021)
6.7.5 Siemens Healthcare Recent Developments
6.8 Abbott
6.8.1 Abbott Company Details
6.8.2 Abbott Business Overview
6.8.3 Abbott Biomarkers Introduction
6.8.4 Abbott Biomarkers Revenue in China Market (2016-2021)
6.8.5 Abbott Recent Developments
6.9 Agilent Technologies
6.9.1 Agilent Technologies Company Details
6.9.2 Agilent Technologies Business Overview
6.9.3 Agilent Technologies Biomarkers Introduction
6.9.4 Agilent Technologies Biomarkers Revenue in China Market (2016-2021)
6.9.5 Agilent Technologies Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer

List of Tables
Table 1. Biomarkers Market Opportunities & Trends in China Market
Table 2. Biomarkers Market Drivers in China Market
Table 3. Biomarkers Market Restraints in China Market
Table 4. Key Players of Biomarkers in China Market
Table 5. Top Biomarkers Players in China Market, Ranking by Revenue (2019)
Table 6. China Biomarkers Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Biomarkers Revenue Share by Companies, 2016-2021
Table 8. Companies Biomarkers Product Type
Table 9. List of Tier 1 Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type Ð China Biomarkers Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Biomarkers Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Biomarkers Revenue (US$, Mn), 2022-2027
Table 14. By Application Ð China Biomarkers Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Biomarkers Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Biomarkers Revenue (US$, Mn), 2022-2027
Table 17. Thermo Fisher Scientific Company Details
Table 18. Thermo Fisher Scientific Business Overview
Table 19. Thermo Fisher Scientific Biomarkers Product
Table 20. Thermo Fisher Scientific Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Thermo Fisher Scientific Recent Developments
Table 22. Merck Company Details
Table 23. Merck Business Overview
Table 24. Merck Biomarkers Product
Table 25. Merck Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Merck Recent Developments
Table 27. Bio-Rad Laboratories Company Details
Table 28. Bio-Rad Laboratories Business Overview
Table 29. Bio-Rad Laboratories Biomarkers Product
Table 30. Bio-Rad Laboratories Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Bio-Rad Laboratories Recent Developments
Table 32. QIAGEN Company Details
Table 33. QIAGEN Business Overview
Table 34. QIAGEN Biomarkers Product
Table 35. QIAGEN Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 36. QIAGEN Recent Developments
Table 37. Roche Company Details
Table 38. Roche Business Overview
Table 39. Roche Biomarkers Product
Table 40. Roche Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Roche Recent Developments
Table 42. Danaher Corporation Company Details
Table 43. Danaher Corporation Business Overview
Table 44. Danaher Corporation Biomarkers Product
Table 45. Danaher Corporation Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Danaher Corporation Recent Developments
Table 47. Siemens Healthcare Company Details
Table 48. Siemens Healthcare Business Overview
Table 49. Siemens Healthcare Biomarkers Product
Table 50. Siemens Healthcare Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Siemens Healthcare Recent Developments
Table 52. Abbott Company Details
Table 53. Abbott Business Overview
Table 54. Abbott Biomarkers Product
Table 55. Abbott Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Abbott Recent Developments
Table 57. Agilent Technologies Company Details
Table 58. Agilent Technologies Business Overview
Table 59. Agilent Technologies Biomarkers Product
Table 60. Agilent Technologies Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Agilent Technologies Recent Developments
List of Figures
Figure 1. Biomarkers Segment by Type
Figure 2. Biomarkers Segment by Application
Figure 3. China Biomarkers Market Overview: 2020
Figure 4. China Biomarkers Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Biomarkers Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Biomarkers Revenue in 2020
Figure 7. By Type - China Biomarkers Revenue Market Share, 2016-2027
Figure 8. By Application - China Biomarkers Revenue Market Share, 2016-2027
Figure 9. Thermo Fisher Scientific Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Merck Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bio-Rad Laboratories Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. QIAGEN Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Roche Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Danaher Corporation Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Siemens Healthcare Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Abbott Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Agilent Technologies Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.